NCT03431168 (PREMISE).

Study name	The PREMISE trial: a novel regimen to prevent malaria and sexually transmitted infections in pregnant women with HIV
Methods	Double‐blinded, phase II RCT
Participants	308 pregnant women with HIV in Cameroon
Interventions	Azithromycin/CTXp vs placebo/CTXp
Outcomes	The primary outcomes are Plasmodium falciparum peripheral parasitaemia and proportion of participants with composite STI outcome. Secondary outcomes include clinical malaria, placental malaria, maternal anaemia, low birth weight, and adverse birth outcomes.
Starting date	7 March 2018
Contact information	Jodie Dionne‐Odom, University of Alabama at Birmingham
Notes